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Episodic ataxia type 2 and familial hemiplegic migraine are two rare hereditary disorders that are linked to dysfunctional ion
channels and are characterized clinically by paroxysmal neurological symptoms. Impaired regulation of cerebral excitability is
thought to play a role in the occurrence of these paroxysms, but the underlying mechanisms are poorly understood. Normal ion
channels are crucial for coordinating neuronal firing in response to facilitatory input. Thus, we hypothesized that channel
dysfunction in episodic ataxia type 2 and familial hemiplegic migraine may impair the ability to adjust cerebral excitability
after facilitatory events. We tested this hypothesis in patients with episodic ataxia type 2 (n = 6), patients with familial hemi-
plegic migraine (n = 7) and healthy controls (n = 13). All subjects received a high-frequency burst (10 pulses at 20Hz) of
transcranial magnetic stimulation to transiently increase the excitability of the motor cortex. Acute burst-induced excitability
changes were probed at 50, 250, 500 and 1000ms after the end of the burst. This was done using single-pulse transcranial
magnetic stimulation to assess corticospinal excitability, and paired-pulse transcranial magnetic stimulation at an interstimulus
interval of 2 and 10ms to assess intracortical inhibition and facilitation, respectively. The time course of burst-induced excit-
ability changes differed between groups. Healthy controls showed a short-lived increase in excitability that was only present
50ms after the burst. In contrast, patients with episodic ataxia type 2 showed an abnormally prolonged increase in corticospinal
excitability that was still present 250ms after the transcranial magnetic stimulation burst. Furthermore, while controls showed a
decrease in intracortical facilitation during the 1 s period following the transcranial magnetic stimulation burst, patients with
episodic ataxia type 2 had increased intracortical facilitation 1000ms after the burst. Intracortical inhibition was unaltered
between groups. Patients with familial hemiplegic migraine were not significantly different from either controls or patients
with episodic ataxia type 2. Together, these findings indicate that patients with episodic ataxia type 2 have an excessive
increase in motor cortex excitability following a strong facilitatory input. We argue that this deficient control of cortical excit-
ability may set the stage for the emergence of paroxysmal neural dysfunction in this disorder.
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Introduction
Familial hemiplegic migraine and episodic ataxia type 2 (EA2)
are two rare, hereditary paroxysmal disorders that are caused by
dysfunctional ion channels. Both the disorders are thought to
result from impaired regulation of neuronal excitability, but the
underlying mechanisms are unknown. Understanding these mech-
anisms could provide important insights into the physiological
role of these ion channels, and in the neural changes mediating
the occurrence of paroxysmal attacks in both disorders (Catterall
et al., 2008). Familial hemiplegic migraine is a subtype of migraine
with aura, where the aura consists of motor weakness (hemi-
paresis) (International Headache Society, 2004). EA2 is character-
ized by spontaneous episodes of ataxia, with many patients also
developing interictal nystagmus and progressive ataxia (Jen et al.,
2004). Despite these apparent clinical differences, there is also
considerable overlap in the symptoms of familial hemiplegic mi-
graine and EA2. For example, many patients with familial
hemiplegic migraine show permanent cerebellar signs (Wessman
et al., 2007), whereas more than half of the patients with
EA2 fulfil the International Headache Society criteria for migraine
and some patients with EA2 experience episodes of paresis
(Jen et al., 2004).
The pathophysiology of familial hemiplegic migraine and EA2
has been related to specific mutations that give rise to dysfunc-
tional neuronal ion channels. Familial hemiplegic migraine has
been linked to three different mutations affecting the function
of presynaptic voltage-gated calcium channels (FHM1) (Ophoff
et al., 1996), the sodium–potassium pump (FHM2) (Ducros
et al., 1997; Gardner et al., 1997) or voltage-gated sodium chan-
nels (FHM3) (Dichgans et al., 2005). EA2 is allelic with FHM1 and
this mutation also causes dysfunctional voltage-gated calcium
channels (Vahedi et al., 1995). Although the exact site of the
mutation differs between FHM1 and EA2, an identical mutation
in the CACNA1A gene can give rise to both EA2 and hemiplegic
migraine within one pedigree (Jen et al., 1999). These findings
suggest that EA2 and familial hemiplegic migraine share a similar
pathophysiological pathway.
To test for in vivo effects of ion channel dysfunction on cerebral
excitability in patients with EA2 and familial hemiplegic migraine,
we used transcranial magnetic stimulation (TMS) to measure
corticomotor excitability. TMS is a well recognized method to
measure the excitability of corticospinal output neurons and is
sensitive to trans-synaptic and intrinsic changes in corticospinal
excitability (Kobayashi and Pascual-Leone, 2003). In familial hemi-
plegic migraine, two previous TMS studies have given conflicting
results; no changes were found in one study (Werhahn et al.,
2000), whereas the other found increased motor thresholds
in patients with familial hemiplegic migraine (van der Kamp
et al., 1997). To date there have been no TMS studies that inves-
tigated cortical excitability in EA2, so the net effect of this
CACNA1A mutation on cortical excitability is still unclear.
Here we used TMS to test a novel hypothesis about altered
corticomotor excitability in EA2 and familial hemiplegic migraine.
In contrast to previous work, we focused on changes in the tem-
poral dynamics of cortical excitability in EA2 and familial hemiple-
gic migraine. We hypothesized that EA2 and familial hemiplegic
migraine are associated with altered responses of cortical neurons
to transient excitatory events. This hypothesis is based on evidence
that intact neuronal ion channels are essential for dynamically
coordinating neuronal firing. Specifically, voltage-gated calcium
channels allow calcium to enter the cell, which triggers the release
of glutamate into the synaptic cleft, but it also rapidly terminates
synaptic transmission, e.g. by acting on calcium-gated potassium
channels (Stocker, 2004; Faber and Sah, 2007). Furthermore,
calcium channels are important for adapting synaptic strength to
the previous history of stimulation (short-term synaptic plasticity),
e.g. by inhibiting synaptic transmission after repetitive firing
(Xu and Wu, 2005; Kim et al., 2007; Xu et al., 2007; Catterall
and Few, 2008). Accordingly, it has been suggested that ion chan-
nel dysfunction disturbs the temporal coordination of synaptic
transmission in EA2 (Walter et al., 2006) and familial hemiplegic
migraine (Pietrobon, 2010). Finally, altered kinetics of mutated ion
channels may further contribute to these alterations. For example,
slower inactivation of calcium currents after repetitive firing has
been observed in cultured neurons with the EA2 (Spacey et al.,
2004) and familial hemiplegic migraine mutation (Tottene et al.,
2005), which may produce abnormally prolonged synaptic trans-
mission. Together, this leads to our hypothesis that ion channel
dysfunction in familial hemiplegic migraine and EA2 may produce
altered dynamics of corticomotor excitability after facilitatory
input, which could trigger paroxysmal attacks (Wessman et al.,
2007). To test this, we applied high-frequency bursts of TMS
pulses to transiently increase the excitability of the motor cortex.
By probing the time course of burst-induced excitability changes
between 50 and 1000 ms after the end of the burst, we could
measure and compare the temporal dynamics of cortical excit-
ability across groups. This was done with single and paired-pulse
TMS using the same coil through which burst TMS had been
applied.
Materials and methods
Subjects
We studied seven patients with familial hemiplegic migraine [one male;
age 43.0 10.2 years (mean SD)], six patients with EA2 (three
males; age 40.3 17.7 years) and 13 healthy subjects (seven males;
mean age 42.2 16.5 years; Table 1). All subjects were right-handed.
Age and gender did not significantly differ between groups [age:
F(2,27) = 0.05; P= 0.95; gender: chi = 3.1; P = 0.21). The experiments
were performed with the approval of the Joint Ethics Committee of
the Institute of Neurology and the National Hospital for Neurology and
Neurosurgery.
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Patients with episodic ataxia type 2
All patients with EA2 had at least one first- or second-degree family
member with similar attacks. Five patients had ataxic attacks; one
patient (EA-04; Table 1) experienced predominantly paretic attacks
without headache. Four patients had interictal symptoms, mostly
ataxia and tremor. Four patients also experienced migraine, associated
with the attack (n= 2) or present between the attacks (n= 2). None
of the patients had symptoms of myokymia, which is characteristic of
EA type 1 (Jen et al., 2007). First onset of symptoms was at an early
age of 12.911.6 years (mean SD). Two patients did not use any
medication. The other patients were measured while on their normal
medication (Table 1). Four of the six patients belonged to one family
(EA-01 to EA-04; Table 1) which has been described previously
(Graves et al., 2008). These patients have a C to G substitution at
nucleotide position 5562 in alternatively spliced exon 37A in the gene
coding the Cav2.1 a1-subunit. This mutation results in a premature
stop (Y1854X) and as a consequence deletion of the entire intracellular
C-terminus of this variant of the Cav2.1 a1-subunit. The remaining
two patients (EA-05 and EA-06) belonged to two different families
that were not genetically tested.
Patients with familial hemiplegic
migraine
All patients were diagnosed with familial hemiplegic migraine accord-
ing to the criteria of the International Headache Society (2004). All
patients experienced migraine attacks with fully reversible motor
weakness (lateralized to one side in six patients) and similar attacks
occurred in at least one first- or second-degree family member. Two
patients did not use any medication. The other patients were mea-
sured while on their normal medication (Table 1). Patients FHM-01
and FHM-02 were sister and brother, patients FHM-03 and FHM-04
were mother and daughter. All patients had other aura symptoms,
mostly sensory disturbances. None of the patients had interictal
symptoms. Age at onset was 16.3 8.7 years (mean SD). Genetic
testing was not performed.
Experimental design
The experiment was designed to measure the temporal evolution of
acute changes in cortical excitability after a short burst of high
frequency repetitive TMS (Fig. 1). To do this, corticomotor excitability
of the hand area of the contralateral primary motor cortex
(M1-HAND) was measured, manipulated with repetitive TMS and
then measured again on a trial-by-trial basis. This was done using a
figure-of-eight coil that was attached to three TMS stimulators via a
specifically designed tri-stim module (Magstim Co., Whitland, Dyfed,
UK). The tri-stim module enabled connection to a Magstim Rapid
stimulator and two Magstim 200 stimulators to the same
figure-of-eight shaped coil placed over the M1-HAND. The Magstim
Rapid stimulator was used to generate 10 high-frequency biphasic
pulses (pulse width of 300ms) at an inter-pulse interval of 50 ms
(i.e. 10-pulse burst at 20 Hz) and intensity of 80% of individual
active motor threshold. Active motor threshold was defined as the
lowest stimulus intensity at which motor evoked potentials of
150 mV amplitude were elicited in the tonically contracting first
dorsal interosseus muscle (10% of maximum voluntary contraction).
The two Magstim 200 stimulators were used to probe regional cortical
excitability in the stimulated M1-HAND before and after the applica-
tion of a single high-frequency burst (Fig. 1). The experimental session
consisted of 120 trials (separated by 10 s), each trial consisting of one
pre-repetitive TMS measurement, one repetitive TMS burst and one
post-repetitive TMS measurement. There were two experimental fac-
tors. First, we measured changes in burst-induced excitability in three
different ways: (i) single pulse TMS to assess corticospinal excitability;
(ii) paired pulse TMS with an interstimulus interval of 2 ms (PP-2) to
assess short-latency intracortical inhibition and; (iii) paired pulse TMS
with an interstimulus interval of 10 ms (PP-10) to assess intracortical
facilitation. Short-latency intracortical inhibition and intracortical facili-
tation were calculated by normalizing the conditioned motor evoked
Table 1 Clinical characteristics
Code Age Gender Medication Symptoms
Provocation Major
symptom
Other symptoms Migraine Site of
attacks
Duration Interictal
EA-01 27 M FL SP, EX, ST AT DI, VO Yes, after attack L4R 46 h DY, TR
EA-02 22 M None SP, EX, ST AT DI No, only headache B 5–20 min None
EA-03 57 F BB, AS SP, ST AT DY, NA, VO, PH, SM Yes (separate attacks) B 45 min None
EA-04 67 M None EX PA No Yes (separate attacks) B 30 s AT, TR
EA-05 34 F FL SP AT Coma, VO Yes, after attack B 12–13 h TR
EA-06 35 F AC ST AT, PA DY No L4R ? AT, NY
FHM-01 50 F OP, BB, AS SP, ST PA SE, VO Yes, during attack R 24–30 h None
FHM-02 36 M TRi, AS, AM SP, ST PA SE, AP, VO Yes, during attack B 1–4 days None
FHM-03 61 F OP, AS SP PA SE, NA, VO, PH, AP Yes, during attack R 2–3 days None
FHM-04 35 F None SP, ST PA SE, DY, PH Yes, during attack R 1–2 days None
FHM-05 39 F FL, AC, TRi SP PA SE, AP Yes (separate attacks) R 3 days None
FHM-06 47 F TO SP PA PH, AP Yes, after attack R 51 week None
FHM-07 33 F None SL PA DY, PH, SE Yes, after attack L 2 days None
The clinical features of six patients with episodic ataxia type 2 (EA2) and seven patients with familial hemiplegic migraine (FHM) are listed.
AC = acetazolamide; AP = aphasia; AS = aspirin; AT = ataxia; AM = acetaminophen; BB = beta-blocker; DI = dizziness; DY = dysarthria; EM = eye movement disorder;
EX = exercise; FL = flunarizine; HE = head trauma; L = left side of the body; MI = migraine; NA = nausea; NY = nystagmus; OP = opioids; PA = paresis; PH = photophobia;
R = right side of the body; SE = sensory symptoms; SL = sleep deprivation; SM = smells; SP = spontaneous; ST = stress; TR = tremor; TRi = triptans; TO = topiramate;
VO = vomiting; ? = not available.
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potential (PP-2 or PP-10) to the single pulse motor evoked potential,
as described by Kujirai et al. (1993). The intensity of the conditioning
stimulus was set to 80% of active motor threshold to avoid floor
or ceiling effects. The intensity of the test stimulus was set at a level
that, when given alone, would evoke an EMG response of 1 mV
peak to peak. Second, we assessed cortical excitability at baseline
(i.e. pre-repetitive TMS measurement) and at four different intervals
(50, 250, 500 and 1000 ms) after the end of the repetitive TMS burst
(i.e. post-repetitive TMS measurement). The pre-repetitive TMS meas-
urement was always performed 5 s before the onset of the repetitive
TMS burst. This gave rise to 15 experimental conditions (Fig. 1). The
pre- and post-repetitive TMS measurements within one trial always
belonged to the same condition, but the order of conditions was
randomized across trials.
Experimental procedures
TMS was applied through a standard figure-of-eight shaped coil over
M1-HAND. The coil was placed tangentially to the scalp, with the
handle pointing backward and laterally at a 45 angle away from
the midline, approximately perpendicular to the central sulcus. This
orientation was chosen because the lowest motor threshold is achieved
when the induced electrical current in the M1-HAND flows approxi-
mately perpendicular to the central sulcus (Brasil-Neto et al., 1992;
Mills et al., 1992). In controls and patients with EA2, repetitive TMS
was always applied over the motor hotspot of the left M1-HAND. In
patients with familial hemiplegic migraine, repetitive TMS was applied
over the motor hotspot of the most affected hemisphere (i.e. the M1
contralateral to the side with predominant hemiparesis; Table 1).
Hence, six patients with familial hemiplegic migraine received
TMS over the left M1-HAND and one patient was stimulated
over the right M1-HAND. We determined the optimal position for
TMS by moving the coil in 0.5 cm steps around the presumed
M1-HAND starting from a position with the coil centre 5 cm lateral
and 1 cm anterior to the vertex. The site at which stimuli of slightly
suprathreshold intensity consistently produced the largest motor
evoked potentials in the contralateral first dorsal interosseus muscle
was marked as the ‘hotspot’. The coil was held by hand in relation
to marks made on the scalp indicating each subject’s motor hotspot.
After defining the motor hotspot, we determined the individual motor
threshold, expressed as a percentage of maximum stimulator output.
Resting motor threshold was defined as the minimum stimulus inten-
sity that produced a motor evoked potential of 450 mV in 5 out of 10
consecutive trials.
Electromyography recordings
Motor evoked potentials were recorded with surface EMG using
1-cm-diameter silver chloride disk electrodes placed over the contra-
lateral first dorsal interosseus muscle. The EMG signal was amplified,
analogue filtered (32 Hz to 1 kHz) by a Digitimer D150 amplifier
(Digitimer Ltd., Welwyn Garden City, Herts, UK), and acquired at a
sampling rate of 5 kHz. Data were stored on a personal computer for
off-line analysis (Signal software; Cambridge Electronic Devices,
Cambridge, UK). During the experiments, EMG activity was continu-
ously monitored with visual (oscilloscope) and auditory (speakers)
feedback. Subjects were seated comfortably in a reclining chair and
were instructed to relax but to keep their eyes open and fixed on a
target directly in front of them.
Statistical analysis: dynamic regulation
of repetitive transcranial magnetic
stimulation-induced excitability
We tested for alterations in the time course of corticomotor excitability
induced by high-frequency repetitive TMS bursts (dynamic regulation
of corticomotor excitability). This was achieved in two different ways.
First, we compared the time course of corticospinal excitability be-
tween groups. Thus, for the single pulse condition, we normalized
the different post-repetitive TMS measurements to the pre-repetitive
TMS measurement (amplitude ratio of post-repetitive TMS motor
Figure 1 Experimental design. Each trial consisted of one baseline measurement (left, in blue), followed by a repetitive TMS (rTMS) train
(centre, in orange; duration 500 ms) and one post-repetitive TMS measurement (right, in red). The baseline measurement consisted of one
of the three possible conditions: single pulse TMS, paired-pulse TMS with an inter-stimulus interval (ISI) of 2 ms (PP-2) or 10 ms (PP-10).
The post-repetitive TMS measurement consisted of one of the three conditions (single pulse, PP-2 or PP-10) and of one of four delays (50,
250, 500 or 1000 ms). Then there was a delay of 10 s before the next trial started. There were 120 trials in total, which were randomized
over conditions for each subject. AMT = active motor threshold.
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evoked potential to pre-repetitive TMS motor evoked potential).
This normalization procedure facilitates a comparison between
groups and it was justified by the absence of significant pre-repetitive
TMS differences (see below). Using these normalized motor evoked
potential values as the dependent variable, we assessed the effects of
factors Group (three levels: controls, EA2 and familial hemiplegic
migraine) and Time (four levels: 50, 250, 500 and 1000 ms post-
repetitive TMS) in a two-way ANOVA. Second, we compared the
time course of intracortical facilitation and short-latency intracortical
inhibition between groups. Thus, for each paired pulse condition (PP-
10 and PP-2), we normalized the paired pulse motor evoked potential
to the single pulse motor evoked potential (amplitude ratio), separately
for each time point. Using these normalized motor evoked potential
values as the dependent variable, for each condition we assessed the
effects of factors Group (three levels: controls, EA2 and familial hemi-
plegic migraine) and Time (five levels: pre-repetitive TMS and 50, 250,
500 and 1000 ms post-repetitive TMS) in a two-way ANOVA. The
Greenhouse-Geisser correction was used to correct for non-sphericity
when applicable. A P5 0.05 was considered significant for all statis-
tical analyses. Conditional upon a significant GroupTime interaction,
we performed post hoc two-samples t-tests to test for group differ-
ences at specific time points.
Statistical analysis: static regulation of
corticomotor excitability
We also tested for altered corticomotor excitability without condi-
tioning repetitive TMS bursts (static regulation of corticomotor
excitability). This was done in three different ways. First, we compared
the size of the resting motor threshold and active motor threshold
between groups by performing a two-way ANOVA with factors
Group (controls, EA2 and familial hemiplegic migraine) and
Threshold (active motor threshold, resting motor threshold). Second,
we compared the amount of pre-repetitive TMS intracortical facilita-
tion and short-latency intracortical inhibition (motor evoked potential
size normalized to the single pulse condition) between groups by per-
forming a two-way ANOVA with factors Group (three levels: controls,
EA2, familial hemiplegic migraine) and TMS condition (two levels:
intracortical facilitation and short-latency intracortical inhibition).
Third, we compared the size of the absolute pre-repetitive TMS
motor evoked potential to single pulse TMS, to PP-10 and to PP-2
between groups by using a two-way ANOVA with factors Group
(three levels: controls, EA2 and familial hemiplegic migraine) and
TMS condition (three levels: single pulse, PP-10 and PP-2).
Statistical analysis: changes in
corticomotor excitability over trials
Finally, we tested for changes in pre-repetitive TMS excitability during
the time of measuring. This was done to rule out the possibility that
the transient burst-induced effects were driven by gradual changes
in baseline excitability. For each condition (single pulse, intracortical
facilitation and short-latency intracortical inhibition), we divided the
40 pre-repetitive TMS trials into four bins (i.e. trial 1–10, 11–20,
21–30 and 31–40) and we calculated the average response for each
time bin. Then we used these values as the dependent measure in an
ANOVA with factors Group (controls, EA2 and familial hemiplegic
migraine) and Time (Bin 1, 2, 3 and 4).
Results
Alterations in the dynamic regulation of
repetitive TMS-induced corticomotor
excitability
We started by assessing the effects of high-frequency repetitive
TMS bursts on the time course of corticomotor excitability in healthy
controls, patients with EA2 and patients with familial hemiplegic
migraine. A two-way ANOVA on single pulse motor evoked
potentials revealed a significantly altered time course between the
three groups [Group Time interaction: F(6,69) = 2.6, P= 0.025;
Fig. 2A]. This effect was driven by prolonged hyperexcitability in
patients with EA2, as compared to controls [Group Time inter-
action: F(3,51) = 3.3, P= 0.027]. Post hoc t-tests revealed that pa-
tients with EA2 had a significantly higher corticomotor excitability at
250 ms than controls [t(17) = 2.3, P= 0.035, two-samples t-test; Fig.
2A). Patients with familial hemiplegic migraine were not significantly
different from either controls [no GroupTime interaction:
F(3,54) = 1.8, P= 0.16)] or from patients with EA2 [no
GroupTime interaction: F(3,33) = 2.3, P= 0.093].
Alterations in the dynamic regulation
of repetitive TMS-induced intracortical
facilitation and short-latency
intra-cortical inhibition
We assessed the effect of high-frequency repetitive TMS bursts
on intracortical facilitation and short-latency intracortical inhibition.
This was done by testing for changes in conditioned motor
evoked potentials relative to single pulse motor evoked potentials
(amplitude ratio). First, a two-way ANOVA on the amount of
intracortical facilitation revealed a significantly altered time
course between groups [GroupTime interaction: F(8,92) = 2.1,
P= 0.047; Fig. 2B]. This effect was mainly driven by a prolonged
hyperexcitability in patients with EA2, as compared to controls
[GroupTime interaction: F(4,68) = 3.4, P= 0.013]. Post hoc
t-tests revealed that patients with EA2 had a significantly
higher intracortical facilitation at 1000 ms post-repetitive TMS,
as compared to healthy controls [t(17) = 2.2, P= 0.040, two-
samples t-test; Fig. 2B]. Patients with EA2 also had lower intra-
cortical facilitation at 50 ms post-repetitive TMS than controls
[t(14.7) =2.4, P= 0.029, two-samples t-test]. However, since
intracortical facilitation is expressed as the amplitude ratio of
motor evoked potentials to conditioned versus single pulse TMS,
the early (5500 ms) repetitive TMS-induced changes in
EA2 are most likely driven by the increased corticomotor ex-
citability to single pulse TMS at these time points (Fig. 2A).
Importantly, these effects did not account for the increased
intracortical facilitation at 1000 ms, because at that time point
corticomotor excitability to single pulse TMS was unaltered [EA2
versus control patients, t(17) = 0.40, P= 0.70, two-samples t-test;
Fig. 2A]. The familial hemiplegic migraine group was not different
from either controls [no Group Time interaction: F(4,72)5 1,
P= 0.68], or from patients with EA2 [no Group Time
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interaction: F(4,44) = 1.9, P= 0.13]. Second, a two-way ANOVA
on the amount of short-latency intracortical inhibition showed no
significant changes over time [no main effect of Time: F(4,92)51,
P= 0.58] and there were no differences between groups [no
Group Time interaction: F(8,92) = 1.6, P= 0.14.
Subgroup analysis
Genetic information was available for four patients with EA2,
who all had a loss-of-function mutation in the CACNA1A
gene [these subjects are described in more detail by Graves
et al. (2008)]. To test whether these patients showed the same
effects as described earlier, we compared this subgroup with
the 13 healthy controls. We found that this homogeneous
and genetically characterized family of patients with EA2 had
the same altered time course of single pulse motor evoked
potentials [Group Time interaction: F(3,45) = 4.3, P= 0.009],
the same altered time course of paired pulse motor evoked
potentials [PP-10; F(3,45) = 4.1; P= 0.010], and the same altered
time course of intracortical facilitation [Group Time interaction:
F(4,60) = 3.0, P= 0.024]. This provides more direct evidence
for the involvement of deficient voltage-gated P/Q type
calcium channels in the dynamic regulation of corticomotor
excitability.
Figure 2 Effect of repetitive TMS conditioning on corticomotor excitability, intra-cortical facilitation and short-latency intra-cortical
inhibition. (A) The change in motor cortex excitability induced by the repetitive TMS bursts, as measured with single pulse motor evoked
potentials (MEP). Motor evoked potential size (on the y-axis) is normalized to the pre-repetitive TMS condition, which is set at 100%. The
x-axis shows the time delay since the end of the repetitive TMS (rTMS) burst (in ms), separately for each group. Healthy controls (n= 13)
showed a transient facilitatory effect at 50 ms, which was present for all three conditions (Table 2). Patients with EA2 (n= 6) showed a
significantly prolonged hyperexcitability to single pulse TMS at 250 ms, whereas patients with familial hemiplegic migraine (FHM) (n= 7)
were not significantly different from controls. (B) The change in intracortical facilitation (ICF) induced by the repetitive TMS bursts. Motor
evoked potential size (on the y-axis) represents the ratio of paired pulse motor evoked potential to single pulse motor evoked potential
(which is set at 100%), separately for each time point. Patients with EA2 showed a significantly altered time course of intracortical
facilitation, with relatively increased intracortical facilitation at 1000 m post-repetitive TMS (* in panel B indicates a P5 0.05 for a
two-samples t-test between patients with EA2 and controls). Patients with familial hemiplegic migraine did not show significant changes in
intracortical facilitation. (C) The change in short-latency intracortical inhibition (SICI) induced by the repetitive TMS bursts. Motor evoked
potential size (on the y-axis) represents the ratio of paired pulse motor evoked potential to single pulse motor evoked potential (which is
set at 100%), separately for each time point. There were no group differences in short-latency intracortical inhibition.
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Static regulation of corticomotor
excitability, intracortical facilitation
and short-latency intracortical inhibition
Comparison of the motor thresholds between groups showed that
the mean resting motor threshold was consistently higher than
mean active motor threshold [main effect of Threshold:
F(1,21) = 117.04, P50.001], but there was no main effect of
Group and no Group Threshold interaction (Fig. 3A).
Furthermore, comparison of pre-repetitive TMS intracortical facili-
tation and short-latency intracortical inhibition (expressed as the
amplitude ratio of conditioned motor evoked potential to single
pulse motor evoked potential) between groups revealed a prom-
inent main effect of TMS condition [F(1,23) = 73.6, P5 0.001; Fig.
3B], but no effect of Group (P= 0.25) and no interaction between
Group and TMS condition (P= 0.92). The same effect was
observed when we performed statistics on absolute motor
evoked potential size (pre-repetitive TMS motor evoked potential
to single pulse TMS, PP-2, and PP-10). Specifically, there was a
significant effect of TMS condition [F(2,46) = 38.1, P50.001;
Table 2], but no effect of Group (P= 0.36) and no interaction
between Group and TMS condition (P= 0.37). Post hoc t-tests
revealed that motor evoked potentials to PP-2 were significantly
smaller than motor evoked potentials to single pulse TMS
[t(25) = 7.1, P50.001; paired-samples t-test], that motor
evoked potentials to PP-10 were significantly larger than motor
evoked potentials to single pulse TMS [t(25) =3.4, P= 0.002;
paired-samples t-test] and that motor evoked potentials to PP-
10 were significantly larger than motor evoked potentials to PP-
2 [t(25) =7.4, P50.001; paired-samples t-test]. Overall, these
findings indicate that the static excitability of intracortical inhibi-
tory and facilitatory circuits was similar between groups.
Figure 3 Baseline measurements. (A) Baseline measurements consisted of the active (AMT) and resting (RMT) motor thresholds. Resting
motor threshold was always higher than active motor threshold, but there were no differences between groups. (B) Paired-pulse
measurements before the repetitive TMS trains showed clear intracortical inhibition (SICI, in black) and intracortical facilitation (ICF, in
grey) with respect to single pulse TMS, dependent on the interstimulus interval between conditioning pulse and test pulse (2 ms for
short-latency intracortical inhibition, 10 ms for intracortical facilitation). These effects were similar between groups. MEP = motor evoked
potential.
Table 2 Absolute motor evoked potential values
Group Condition Motor evoked potential size (mV) (mean SEM)
Baseline 50 250 500 1000
Controls (n= 13) SP 0.98 (0.14) 1.21 (0.20)* 0.97 (0.17) 0.94 (0.14) 0.93 (0.16)
PP-2 0.55 (0.11) 0.75 (0.13)** 0.64 (0.12) 0.49 (0.09) 0.41 (0.07)
PP-10 1.25 (0.20) 1.54 (0.24)** 1.21 (0.20) 1.22 (0.22) 1.05 (0.18)
EA2 (n= 6) SP 0.68 (0.09) 0.89 (0.18) 0.91 (0.15) 0.68 (0.11) 0.68 (0.14)
PP-2 0.37 (0.10) 0.44 (0.06) 0.40 (0.11) 0.46 (0.14) 0.35 (0.10)
PP-10 0.86 (0.09) 0.93 (0.18) 0.93 (0.17) 0.94 (0.21) 1.01 (0.12)
FHM (n= 7) SP 1.10 (0.17) 1.24 (0.25) 1.15 (0.23) 1.19 (0.23) 1.11 (0.22)
PP-2 0.42 (0.13) 0.55 (0.12)* 0.49 (0.11) 0.50 (0.13) 0.50 (0.16)
PP-10 1.19 (0.18) 1.29 (0.23) 1.41 (0.25) 1.31 (0.19) 1.29 (0.20)
The absolute motor evoked potential values (in mV, mean standard error of the mean; SEM) for all 15 experimental conditions, separately for each group.
FHM = familial hemiplegic migraine; PP-2 = paired pulse TMS with an interstimulus interval of 2 ms (inhibitory); PP–10 = paired pulse TMS with an interstimulus interval of
10 ms (facilitatory); SP = single pulse TMS. The baseline column refers to the pre-repetitive TMS condition; the other columns refer to the time delay (in ms) since the end of
the repetitive TMS burst.
*Indicates a significant difference between the baseline motor evoked potential and the post-repetitive TMS motor evoked potential, where * = P50.05 and ** = P5 0.01
(paired-samples t-test, two-tailed).
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Changes in corticomotor excitability
over trials
By separating the trials by 10 s, we purposely aimed to minimize
gradual changes in corticomotor excitability over trials. It might be
argued that the prolonged excitability in patients with familial
hemiplegic migraine and EA2 could nevertheless cause a gradual
increase in corticomotor excitability during the experiment, which
may influence the repetitive TMS effects. We found that the amp-
litude of motor evoked potentials to single pulse TMS at baseline
did not change over the course of four time bins [no effect of
Time; F(3,66) = 1.3, P= 0.28; no GroupTime interaction:
F(6,66) = 1.1, P= 0.39]. There were also no effects for intracortical
facilitation [no effect of Time: F(3,66)5 1; no GroupTime inter-
action: F(6,66)41] or for short-latency intracortical inhibition [no
effect of Time: F(3,66) = 1.2, P= 0.32; no GroupTime inter-
action: F(6,66) = 1.3, P= 0.25]. This indicates that the short-term
effects reported here are not confounded by gradual changes in
corticomotor excitability over trials.
Discussion
In this study, we tested the hypothesis that EA2 and familial hemi-
plegic migraine have altered time-varying responses to transient
excitatory events. We investigated this by applying high-frequency
bursts of TMS pulses to increase transiently the excitability of the
motor cortex, and probed the time course of burst-induced excit-
ability changes between 50 and 1000 ms after the end of the
burst. There are three main findings. First, patients with EA2
showed a different time course of burst-induced excitability than
controls, which was evident as: (i) prolonged corticomotor excit-
ability to single pulse TMS, lasting up to 250 ms after the burst;
and (ii) increased intracortical facilitation at 1000 ms after the
burst. Second, patients with familial hemiplegic migraine were
not significantly different from either controls or patients with
EA2. Third, patients with EA2 and familial hemiplegic migraine
showed normal excitability at baseline (intracortical facilitation,
short-latency intracortical inhibition and motor thresholds), and
there were no differences in the time course of short-latency
intracortical inhibition. These findings suggest that patients with
EA2 are impaired in tuning down facilitatory responses to strong
excitatory input. We relate this finding to dysfunctional voltage-
gated calcium channels, and propose that our results may explain
the occurrence of paroxysmal events in these patients.
Regulation of cortical excitability in
healthy subjects
Previous studies in healthy subjects showed that brief repetitive
TMS trains can evoke both cortical facilitation (Berardelli et al.,
1998) and inhibition (Modugno et al., 2001; Arai et al., 2009),
depending on the intensity and duration of stimulation (Modugno
et al., 2001), as well as the time of measurement after the repeti-
tive TMS train (Huang and Rothwell, 2004). The effects of longer
repetitive TMS trains on cortical excitability have been related to
long-term potentiation and depression (Hoffman and Cavus,
2002), possibly mediated by post-synaptic calcium channels
(Wankerl et al., 2010). In contrast, the transient (i.e. 51 s) effects
of short repetitive TMS trains follow the same time scale as
short-term synaptic plasticity that occurs in the order of milli-
seconds to minutes (Xu et al., 2007; Catterall and Few, 2008).
These effects are most likely mediated in the cortex, given that (i)
spinal excitability (measured with H-reflexes) remained unaltered
in most studies (Modugno et al., 2001; Huang and Rothwell,
2004; Huang et al., 2005); and (ii) the repetitive TMS bursts
were applied at a very low stimulation intensity (80% active
motor threshold) that does not directly activate the corticospinal
tract. Further support for this idea comes from animal work, where
the effect of TMS on single-unit activity in the cat visual cortex
was investigated (Moliadze et al., 2003; Allen et al., 2007).
Interestingly, the authors found TMS-induced facilitation up to
200 ms after the end of the pulse that was followed by more pro-
longed cortical inhibition (Moliadze et al., 2003). This temporal pat-
tern is consistent with our findings in healthy subjects.
Regulation of cortical excitability in
patients with episodic ataxia type 2
Patients with EA2 showed clear differences in the dynamic regu-
lation of excitability compared to controls, whereas both groups
had comparable static regulation of excitability. Whereas controls
had only transient increases in burst-induced excitability, patients
with EA2 showed abnormally prolonged corticomotor hyperexcit-
ability up to 250 ms (to single pulse TMS), and increased intracor-
tical facilitation at 1000 ms after the burst. We suspect that early
changes in intracortical facilitation may have been masked by the
early (5500 ms) and pronounced increase in corticomotor excit-
ability observed in EA2 (Fig. 2A). For this reason, we are careful to
make specific inferences about the timing of intracortical facilita-
tion changes. Still, it should be noted that the increased intracor-
tical facilitation at 1000 ms occurred in the context of unaltered
responses to single pulse TMS (no differences with respect to
baseline at that time point; Fig. 2A). This indicates that the altered
intracortical facilitation is not an artefact of increased excitability to
single pulse TMS (Florian et al., 2008; Alle et al., 2009).
Although patients with EA2 showed significant changes in intra-
cortical facilitation, there were no group differences in the
dynamic regulation of short-latency intracortical inhibition
(Fig. 2C). If short-latency intracortical inhibition and intracortical
facilitation are mediated by distinct populations of cortical inter-
neurons (Reis et al., 2008), then this implies that EA2 preferen-
tially affects facilitatory intracortical circuits. In a mouse model of
FHM1, which is based on a mutation in the same CACNA1A gene
as EA2, such population-specific effects have been shown. For
example, the affected Cav2.1 Ca
2+ channel functioned normally
in some types of neurons but abnormally in others, depending on
the duration of the action potential in the neuron (Inchauspe
et al., 2010). Interestingly, another study showed that the
FHM1 mutation severely affected excitatory cortical neurotrans-
mission, but left inhibitory neurotransmission at fast spiking inter-
neurons intact (Tottene et al., 2009). If similar mechanisms apply
to EA2, then this might explain why alterations were present for
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intracortical facilitation, but not for short-latency intracortical
inhibition.
The abnormal regulation of excitability in EA2 is probably
related to dysfunctional Cav2.1 Ca
2+ channels, which is the patho-
physiological hallmark of the disease (Pietrobon, 2010). Most
previous studies investigated the functional consequences of EA2
mutations at the level of a single channel in a single cell, whereas
we focused on net excitability changes in human patients with
EA2. Although it is difficult to translate single-cell characteristics
into in vivo excitability changes, the following mechanisms may
account for our results. First, whole cell patch-clamp recordings
have shown altered kinetics of the affected Cav2.1 Ca
2+ channel in
EA2, such that the current decay after repetitive stimulation
(at 1 Hz) was slower than for normal Cav2.1 Ca
2+ channels. This
could lead to prolonged synaptic transmission, which would fit
with our findings. Second, the mutated Cav2.1 Ca
2+ channel of
patients with EA2 is thought to be important for normal short-
term synaptic plasticity (Catterall and Few, 2008). Short-term
synaptic plasticity shapes the postsynaptic response to bursts of
impulses and is crucial for encoding information in neurons
(Mochida et al., 2008). For example, calcium-dependent inactiva-
tion of the presynaptic calcium current causes rapid synaptic
depression for stimuli ranging from 2 to 30 Hz (Xu and Wu
2005). Thus, impairments in short-term synaptic depression may
prevent inhibitory responses after a burst of stimuli, which would
be consistent with the prolonged hyperexcitability that we found
in EA2. Third, the reduced calcium current in EA2 may have
downstream effects on ion channels that are activated by intra-
cellular Ca2+, for example calcium-activated potassium channels
(KCa). In a mouse model of EA2, reduced activation of KCa chan-
nels has been linked to irregular firing of cerebellar Purkinje cells,
which can produce ataxic attacks (Walter et al., 2006). In the
healthy state, activation of KCa channels limits the firing frequency
of neurons by regulating after hyperpolarization following a train
of action potentials. This endows the neuron with the ability to
self-regulate its activity and to curb excessive excitability (Faber
and Sah, 2007). Impaired activation of KCa channels may thus lead
to pathologically prolonged neural activity after facilitatory events.
Finally, compensatory reactions to the loss of functional Cav2.1
Ca2+ channels may play a role. For example, single-cell recordings
in mouse models of EA2 have shown increased Ca2+ sensitivity of
the intracellular release machinery (Piedras-Renteria et al., 2004)
and increased expression of other Ca2+ channel subtypes (i.e.
N-type calcium channels; Inchauspe et al., 2004). We propose
that these alterations in neurotransmission interfere with the ability
of patients with EA2 to regulate the dynamic response to facilita-
tory input. This could lead to abnormally prolonged neuronal
excitability following transient facilitatory events, resulting in
paroxysmal attacks that are characteristic for EA2.
Regulation of cortical excitability in
patients with familial hemiplegic
migraine
In patients with familial hemiplegic migraine, the time course of
burst-induced excitability changes was not significantly different
from healthy controls. We attribute this finding to increased vari-
ability in the familial hemiplegic migraine group, because this dis-
order is linked to mutations in three different genes, whereas EA2
is monogenetic (Pietrobon, 2010). Future research may test
whether subgroups of patients with FHM1, FHM2 and FHM3
have different dynamic responses to brief facilitatory events.
Similar to EA2, the familial hemiplegic migraine group had
normal baseline measures of excitability. This finding is consistent
with a previous report (Werhahn et al., 2000), but not with an-
other study (van der Kamp et al., 1997). Differences between
studies may be explained by different underlying mutations, or
by different disease characteristics (e.g. age, disease severity or
use of prophylactic medication).
Interpretational issues
A few points are important for interpreting our results. First, on
the basis of our results, we cannot draw solid conclusions about
the causal relationship between altered cortical excitability and the
occurrence of attacks. For instance, it is known that the attacks in
familial hemiplegic migraine can leave interictal neurological
abnormalities (Wessman et al., 2007), which may be related to
structural brain damage caused during the attacks (Hayashi et al.,
1998). However, this would predict that patients should also show
alterations on baseline measures of corticomotor excitability, which
is not what we found. Second, it might be argued that the effects
reported here are related to the use of medication by the majority
of patients. However, the results of two patients with EA2 and
two patients with familial hemiplegic migraine without treatment
showed similar changes as the whole group (data not shown).
Therefore, we infer that the altered corticomotor excitability
in EA2 and familial hemiplegic migraine is not a by-product of
medication. Third, different inhibitory mechanisms are thought
to be responsible for the intracortical inhibition occurring at differ-
ent interstimulus intervals (Fisher et al., 2002; Hanajima et al.,
2003). Since we tested inhibition only at an interstimulus interval
of 2 ms, we may have missed changes in inhibitory circuits
mediating intracortical inhibition at other intervals. This could
be tested in future research. Fourth, one might argue that the
small number of subjects in this study limits our findings. While
a larger sample size would certainly be preferable, it is important
to note that familial hemiplegic migraine and EA2 are extremely
rare disorders. For instance, EA2 has an incidence of less than
1/100 000 based on cases seen in expert centres (Jen et al.,
2007), and familial hemiplegic migraine has an estimated preva-
lence of 1/50 000 based on a population-wide search in Denmark
(Lykke et al., 2002). This may explain why to date, no TMS
studies have been performed in EA2, and why only two previous
TMS studies have been performed in familial hemiplegic migraine
(van der Kamp et al., 1997; Werhahn et al., 2000).
Conclusion
Our results support the hypothesis that patients with EA2 have
altered time-varying responses to transient increases in corticomotor
excitability. We relate these findings to the primary deficit of this
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disorder, i.e. dysfunction of voltage-gated calcium channels that
regulate synaptic excitability and plasticity in the central nervous
system. The abnormally prolonged hyperexcitability observed in
EA2 could be a neurophysiological prelude to the occurrence of
clinically visible paroxysmal attacks in these patients.
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